Company intelligence / Profile preview

Yaoshibang

Ownership: Private
Development stage: Other

Overview

Yaoshibang operates the largest digital comprehensive service and distribution platform for the out-of-hospital pharmaceutical industry in China. It connects pharmaceutical companies, distributors, pharmacies, and primary medical institutions to streamline access to medicines and health products at fair prices. The company also offers educational resources for pharmacists and maintains an extensive database of drugs and diseases. It does not conduct clinical trials or develop therapeutics.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Over 700 regular pharmaceutical suppliers across China

Beyond the preview

Go deeper on Yaoshibang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaoshibang.

Explore the full profile